MedTrace Logo

Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study

NCT01578200 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2309

Last updated 2020-11-30

No results posted yet for this study

Summary

The purpose of this study is to demonstrate decrease in cardiovascular mortality and morbidity in Japanese hemodialysis patients treated with Lanthanum carbonate compared with those with Calcium carbonate.

Conditions

  • Hemodialysis
  • Hyperphosphatemia

Interventions

DRUG

Lanthanum Carbonate

DRUG

Calcium Carbonate

Sponsors & Collaborators

  • Showa University School of Medicine

    collaborator UNKNOWN

  • Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

    lead OTHER

Principal Investigators

  • Tadao Akizawa, MD, PhD · Showa University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-24
Primary Completion
2019-03-25
Completion
2019-03-25

Countries

  • Japan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01578200 on ClinicalTrials.gov